{
  "ptid_time": "027_S_0835_2011-09-20",
  "img_path": "/data/qiuhui/data/adni/images/027_S_0835/2011-09-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 46,952 mm³, 21.9% above the reference mean. With a Z-score of 0.52 (70.0th percentile), this represents normal volume ; hippocampal volume measures 4,971 mm³, 34.2% below the reference mean. With a Z-score of -3.34 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,017,980 mm³, 5.7% below the reference mean. With a Z-score of -0.74 (23.0th percentile), this represents normal volume ; entorhinal cortex volume measures 2,469 mm³, 39.8% below the reference mean. With a Z-score of -2.70 (0.3th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,377 mm³, 23.7% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy; middle temporal gyrus volume measures 17,603 mm³, 17.5% below the reference mean. With a Z-score of -1.57 (5.8th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 77.7 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. MMSE: 24.0. MoCA: 17.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.43 SUVR (significant elevated); Amyloid beta: 757.30 pg/mL (normal ); Total tau: 319.10 pg/mL (normal ); Phosphorylated tau: 30.82 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows profound hippocampal atrophy (-3.34 Z-score) and significant atrophy in the entorhinal cortex and fusiform gyrus, which are hallmark features of Alzheimer's disease (AD). Despite normal Aβ levels, elevated AV45 (amyloid PET) suggests amyloid pathology, and mildly elevated P-tau supports AD neurodegeneration. Cognitive scores (MMSE 24, MoCA 17) indicate impairment consistent with dementia.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**  \n\n*(Key findings: Medial temporal atrophy + amyloid positivity + cognitive decline, despite normal CSF Aβ—possibly due to discordance between CSF and PET biomarkers.)*",
  "timestamp": "2025-07-26T03:43:17.549305"
}